甲基苯丙胺使用障碍的神经生物学、临床表现与治疗综述
该综述指出近十年甲基苯丙胺使用率及相关死亡率翻倍,可能成为美国乃至全球下一波物质使用危机。其神经生物学涉及单胺能调节之外的氧化应激、神经毒性与兴奋毒性及神经炎症;临床除精神兴奋症状外还有复杂心脑血管表现。目前无药物治疗,认知行为疗法、行为激活和 contingency management 显示 modest 效果。
要点
- 甲基苯丙胺使用障碍神经生物学涉及氧化应激、神经毒性/兴奋毒性及神经炎症。
- 临床需识别急性精神兴奋之外的心脑血管体征以降低相关死亡率。
- 无药物治疗;认知行为疗法、行为激活和 contingency management 有 modest 效果。
核心结论
- 需更好理解甲基苯丙胺使用障碍的复杂神经生物学并开发针对新生物靶点的干预。
- 将障碍拆分为不同过程并靶向其神经与生物通路可能提高疾病修饰干预的成功率。
- 精神卫生专业人员需接受识别早期心脑血管预警体征的培训以降低相关死亡率。
研究设计与样本
- 本文为综述,检索范围未在摘要中报告。
主要发现
- 过去10年甲基苯丙胺使用率及相关死亡率翻倍。
- 神经生物学涉及单胺能调节之外的氧化应激、神经毒性与兴奋毒性及神经炎症通路。
- 临床表现除急性精神兴奋症状外还包括复杂心脑血管体征和症状。
- 认知行为疗法、行为激活和 contingency management 显示 modest 效果。
关键数值与推荐
- 无药物治疗甲基苯丙胺使用障碍。
临床怎么用
- 临床中应识别甲基苯丙胺使用者的早期心脑血管预警体征。
- 可采用认知行为疗法、行为激活和 contingency management 作为有 modest 效果的干预。
- 针对渴求或情绪相关改变等过程靶向神经与生物通路可能提高干预成功率。
局限性
- 摘要未报告检索范围及纳入研究的偏倚风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The prevalence of and mortality associated with methamphetamine use has doubled during the past 10 years. There is evidence suggesting that methamphetamine use disorder could be the next substance use crisis in the United States and possibly worldwide. OBSERVATION: The neurobiology of methamphetamine use disorder extends beyond the acute effect of the drug as a monoaminergic modulator and includes intracellular pathways focused on oxidative stress, neurotoxic and excitotoxic effects, and neuroinflammation. Similarly, the clinical picture extends beyond the acute psychostimulatory symptoms to include complex cardiovascular and cerebrovascular signs and symptoms that need to be identified by the clinician. Although there are no pharmacologic treatments for methamphetamine use disorder, cognitive behavioral therapy, behavioral activation, and contingency management show modest effectiveness. CONCLUSIONS AND RELEVANCE: There is a need to better understand the complex neurobiology of methamphetamine use disorder and to develop interventions aimed at novel biological targets. Parsing the disorder into different processes (eg, craving or mood-associated alterations) and targeting the neural systems and biological pathways underlying these processes may lead to greater success in identifying disease-modifying interventions. Finally, mental health professionals need to be trained in recognizing early cardiovascular and cerebrovascular warning signs to mitigate the mortality associated with methamphetamine use disorder.
引用
- Paulus MP, Stewart JL. Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder: A Review. JAMA Psychiatry. 2020. PMID: 32267484. doi:10.1001/jamapsychiatry.2020.0246
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。